Document Detail

Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep.
MedLine Citation:
PMID:  11546979     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Hypotension, vasodilation, and vasoplegia are characteristic signs of septic shock. The vasoconstrictive response to catecholamines typically is reduced. A decreased vasopressive effect of catecholamines can be observed in the late phase of hemorrhagic shock. Interestingly, an unaltered vasopressive response to vasopressin can be demonstrated in hemorrhagic shock. In this study, we investigated the vasoconstrictive response to an agonist of the vasopressin receptor, terlipressin, in healthy sheep as well as in ovine hyperdynamic endotoxemia. DESIGN: Prospective controlled trial. SETTING: University research laboratory. SUBJECTS: Six female adult sheep. INTERVENTIONS: Healthy sheep, instrumented for chronic study, received terlipressin (15 microg/kg) as a bolus; 30 mins later, norepinephrine was continuously given for 30 mins. Three hours later, a continuous infusion of endotoxin (Salmonella typhosa, 10 ng x kg(-1) x min(-1)) was started in the same sheep and given for the next 23 hrs. After 20 hrs of endotoxemia, terlipressin and norepinephrine were given as described previously. MEASUREMENTS AND MAIN RESULTS: Hemodynamic parameters were measured before and 30 mins after application of terlipressin and after 30 mins of continuous infusion of norepinephrine. Terlipressin significantly increased systemic vascular resistance index in healthy and endotoxemic sheep (p <.05). The increase was higher in endotoxemic compared with healthy animals (p <.05). Only during endotoxemia, terlipressin increased pulmonary vascular resistance index. This was accompanied by a significant decrease in cardiac index, whereas mean pulmonary arterial pressure did not change after application of terlipressin. Additional treatment with norepinephrine did not further increase systemic vascular resistance index or pulmonary vascular resistance index. CONCLUSIONS: Terlipressin reversed the hemodynamic changes in ovine endotoxemia. However, its pulmonary vasopressive effect might limit its therapeutic use in septic shock.
M Scharte; J Meyer; H Van Aken; H G Bone
Related Documents :
3303379 - Cardiopulmonary exercise testing to assess respiratory impairment in occupational lung ...
2131859 - Graded exercise testing and postthoracotomy complications.
17846299 - Nonlinear power loss during exercise in single-ventricle patients after the fontan: ins...
6526579 - Clinical experience with inspiratory resistive breathing training.
18829339 - Reduced pulmonary inflammatory response during cardiopulmonary bypass: effects of combi...
16728229 - Determinants of exercise function following univentricular versus biventricular repair ...
9797929 - Physical activity before and after exercise in women with chronic fatigue syndrome.
25210699 - The effects of proprioceptive neuromuscular facilitation integration pattern exercise p...
8262699 - Influence of exercise intensity and duration on post-exercise pulmonary diffusion capac...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Critical care medicine     Volume:  29     ISSN:  0090-3493     ISO Abbreviation:  Crit. Care Med.     Publication Date:  2001 Sep 
Date Detail:
Created Date:  2001-09-07     Completed Date:  2001-10-04     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0355501     Medline TA:  Crit Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1756-60     Citation Subset:  AIM; IM    
Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Interactions
Endotoxemia / drug therapy*
Hemodynamics / drug effects*
Lypressin / analogs & derivatives,  pharmacology,  therapeutic use*
Norepinephrine / pharmacology
Vasoconstrictor Agents / pharmacology,  therapeutic use*
Reg. No./Substance:
0/Vasoconstrictor Agents; 14636-12-5/terlipressin; 50-57-7/Lypressin; 51-41-2/Norepinephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis...
Next Document:  Protective effect of tumor necrosis factor-alpha against subsequent endotoxemia in mice is mediated,...